BindingDB logo
myBDB logout
Compile Data Set for Download or QSAR

Found 8 hits from AstraZeneca R & D Griffith University   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Ribosomal protein S6 kinase alpha 5


(Homo sapiens (human))
BDBM50269815
PNG
(25-hydroxy-13(24),15,17-cheilanthatrien-19,25-olid...)
Show SMILES CC1(C)CCC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2CCC(=C)[C@H]1\C=C\C1=CC(=O)OC1O
Show InChI InChI=1S/C25H36O3/c1-16-7-10-20-24(4,18(16)9-8-17-15-21(26)28-22(17)27)14-11-19-23(2,3)12-6-13-25(19,20)5/h8-9,15,18-20,22,27H,1,6-7,10-14H2,2-5H3/b9-8+/t18-,19+,20+,22?,24+,25+/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 4.00E+3n/an/an/an/an/an/a



AstraZeneca R & D Griffith University

Curated by ChEMBL


Assay Description
Inhibition of MSK1 (unknown origin) assessed as [33P] incorporation by scintillation proximity assay


J Nat Prod 64: 300-3 (2001)


Article DOI: 10.1021/np0004597
BindingDB Entry DOI: 10.7270/Q2HT2P3X
More data for this
Ligand-Target Pair
Ribosomal protein S6 kinase alpha 5


(Homo sapiens (human))
BDBM50269821
PNG
(25-hydroxy-13(24),17-cheilanthadien-16,19-olide | ...)
Show SMILES CC1(C)CCC[C@@]2(C)[C@H]1CC[C@@]1(C)[C@H](CC3OC(=O)C=C3CO)C(=C)CC[C@H]21
Show InChI InChI=1S/C25H38O3/c1-16-7-8-21-24(4,18(16)14-19-17(15-26)13-22(27)28-19)12-9-20-23(2,3)10-6-11-25(20,21)5/h13,18-21,26H,1,6-12,14-15H2,2-5H3/t18-,19?,20+,21+,24+,25+/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 4.00E+3n/an/an/an/an/an/a



AstraZeneca R & D Griffith University

Curated by ChEMBL


Assay Description
Inhibition of MSK1 (unknown origin) assessed as [33P] incorporation by scintillation proximity assay


J Nat Prod 64: 300-3 (2001)


Article DOI: 10.1021/np0004597
BindingDB Entry DOI: 10.7270/Q2HT2P3X
More data for this
Ligand-Target Pair
Ribosomal protein S6 kinase alpha 5


(Homo sapiens (human))
BDBM50269820
PNG
(13,16-epoxy-25-hydroxy-17-cheilanthen-19,25-olide ...)
Show SMILES C[C@]12CC[C@H]3[C@@](C)(CC[C@H]4C(C)(C)CCC[C@]34C)[C@@H]1C[C@@H](O2)C1=CC(=O)OC1O
Show InChI InChI=1S/C25H38O4/c1-22(2)9-6-10-23(3)17(22)7-11-24(4)18(23)8-12-25(5)19(24)14-16(29-25)15-13-20(26)28-21(15)27/h13,16-19,21,27H,6-12,14H2,1-5H3/t16-,17+,18-,19+,21?,23+,24-,25+/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 4.00E+3n/an/an/an/an/an/a



AstraZeneca R & D Griffith University

Curated by ChEMBL


Assay Description
Inhibition of MSK1 (unknown origin) assessed as [33P] incorporation by scintillation proximity assay


J Nat Prod 64: 300-3 (2001)


Article DOI: 10.1021/np0004597
BindingDB Entry DOI: 10.7270/Q2HT2P3X
More data for this
Ligand-Target Pair
Ribosomal protein S6 kinase alpha 5


(Homo sapiens (human))
BDBM50269822
PNG
(16,25-dihydroxy-13(24),17-cheilanthadien-19,25-oli...)
Show SMILES CC1(C)CCC[C@@]2(C)[C@H]1CC[C@@]1(C)[C@H](CC(O)C3=CC(=O)OC3O)C(=C)CC[C@H]21
Show InChI InChI=1S/C25H38O4/c1-15-7-8-20-24(4,12-9-19-23(2,3)10-6-11-25(19,20)5)17(15)14-18(26)16-13-21(27)29-22(16)28/h13,17-20,22,26,28H,1,6-12,14H2,2-5H3/t17-,18?,19+,20+,22?,24+,25+/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 4.00E+3n/an/an/an/an/an/a



AstraZeneca R & D Griffith University

Curated by ChEMBL


Assay Description
Inhibition of MSK1 (unknown origin) assessed as [33P] incorporation by scintillation proximity assay


J Nat Prod 64: 300-3 (2001)


Article DOI: 10.1021/np0004597
BindingDB Entry DOI: 10.7270/Q2HT2P3X
More data for this
Ligand-Target Pair
MAP kinase-activated protein kinase 2


(Homo sapiens (human))
BDBM50269821
PNG
(25-hydroxy-13(24),17-cheilanthadien-16,19-olide | ...)
Show SMILES CC1(C)CCC[C@@]2(C)[C@H]1CC[C@@]1(C)[C@H](CC3OC(=O)C=C3CO)C(=C)CC[C@H]21
Show InChI InChI=1S/C25H38O3/c1-16-7-8-21-24(4,18(16)14-19-17(15-26)13-22(27)28-19)12-9-20-23(2,3)10-6-11-25(20,21)5/h13,18-21,26H,1,6-12,14-15H2,2-5H3/t18-,19?,20+,21+,24+,25+/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem
Article
PubMed
n/an/a 9.00E+4n/an/an/an/an/an/a



AstraZeneca R & D Griffith University

Curated by ChEMBL


Assay Description
Inhibition of MAPKAPK2 (unknown origin) assessed as [33P] incorporation by scintillation proximity assay


J Nat Prod 64: 300-3 (2001)


Article DOI: 10.1021/np0004597
BindingDB Entry DOI: 10.7270/Q2HT2P3X
More data for this
Ligand-Target Pair
MAP kinase-activated protein kinase 2


(Homo sapiens (human))
BDBM50269820
PNG
(13,16-epoxy-25-hydroxy-17-cheilanthen-19,25-olide ...)
Show SMILES C[C@]12CC[C@H]3[C@@](C)(CC[C@H]4C(C)(C)CCC[C@]34C)[C@@H]1C[C@@H](O2)C1=CC(=O)OC1O
Show InChI InChI=1S/C25H38O4/c1-22(2)9-6-10-23(3)17(22)7-11-24(4)18(23)8-12-25(5)19(24)14-16(29-25)15-13-20(26)28-21(15)27/h13,16-19,21,27H,6-12,14H2,1-5H3/t16-,17+,18-,19+,21?,23+,24-,25+/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 9.00E+4n/an/an/an/an/an/a



AstraZeneca R & D Griffith University

Curated by ChEMBL


Assay Description
Inhibition of MAPKAPK2 (unknown origin) assessed as [33P] incorporation by scintillation proximity assay


J Nat Prod 64: 300-3 (2001)


Article DOI: 10.1021/np0004597
BindingDB Entry DOI: 10.7270/Q2HT2P3X
More data for this
Ligand-Target Pair
MAP kinase-activated protein kinase 2


(Homo sapiens (human))
BDBM50269822
PNG
(16,25-dihydroxy-13(24),17-cheilanthadien-19,25-oli...)
Show SMILES CC1(C)CCC[C@@]2(C)[C@H]1CC[C@@]1(C)[C@H](CC(O)C3=CC(=O)OC3O)C(=C)CC[C@H]21
Show InChI InChI=1S/C25H38O4/c1-15-7-8-20-24(4,12-9-19-23(2,3)10-6-11-25(19,20)5)17(15)14-18(26)16-13-21(27)29-22(16)28/h13,17-20,22,26,28H,1,6-12,14H2,2-5H3/t17-,18?,19+,20+,22?,24+,25+/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 9.00E+4n/an/an/an/an/an/a



AstraZeneca R & D Griffith University

Curated by ChEMBL


Assay Description
Inhibition of MAPKAPK2 (unknown origin) assessed as [33P] incorporation by scintillation proximity assay


J Nat Prod 64: 300-3 (2001)


Article DOI: 10.1021/np0004597
BindingDB Entry DOI: 10.7270/Q2HT2P3X
More data for this
Ligand-Target Pair
MAP kinase-activated protein kinase 2


(Homo sapiens (human))
BDBM50269815
PNG
(25-hydroxy-13(24),15,17-cheilanthatrien-19,25-olid...)
Show SMILES CC1(C)CCC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2CCC(=C)[C@H]1\C=C\C1=CC(=O)OC1O
Show InChI InChI=1S/C25H36O3/c1-16-7-10-20-24(4,18(16)9-8-17-15-21(26)28-22(17)27)14-11-19-23(2,3)12-6-13-25(19,20)5/h8-9,15,18-20,22,27H,1,6-7,10-14H2,2-5H3/b9-8+/t18-,19+,20+,22?,24+,25+/m1/s1
PDB
MMDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 9.00E+4n/an/an/an/an/an/a



AstraZeneca R & D Griffith University

Curated by ChEMBL


Assay Description
Inhibition of MAPKAPK2 (unknown origin) assessed as [33P] incorporation by scintillation proximity assay


J Nat Prod 64: 300-3 (2001)


Article DOI: 10.1021/np0004597
BindingDB Entry DOI: 10.7270/Q2HT2P3X
More data for this
Ligand-Target Pair